Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P De Vuyst

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
The European Respiratory Journal|November 1, 1994
Chronic eosinophilic pneumonia (CEP) as a presenting feature of Churg-Strauss syndrome (CSS)S Steinfeld, M Golstein, P De Vuyst
The European Respiratory Journal|March 11, 1998
Asbestos, ergot drugs and the pleuraP De Vuyst, P Pfitzenmeyer, P Camus
American Journal of Respiratory and Critical Care Medicine|August 14, 2001
Pseudoasbestos bodies and fibers in bronchoalveolar lavage of refractory ceramic fiber usersP Dumortier, I Broucke, P De Vuyst
The European Respiratory Journal|July 10, 1998
Asbestos, ergot drugs and the pleuraP Camus, G Hillerdal, P De Vuyst
Revue Des Maladies Respiratoires|January 1, 1992
[Broncho-alveolar lavage. From technical aspects to standards of interpretation]B Wallaert, P De Vuyst, D Israel-Biet
The American Review of Respiratory Disease|December 1, 1986
Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosisJ C Yernault, P De Vuyst, P Dumortier
Respiratory Medicine|May 1, 1990
Concentration of tobramycin given by aerosol in the fluid obtained by bronchoalveolar lavageD Baran, P de Vuyst, H A Ooms
American Journal of Industrial Medicine|June 1, 1997
Analysis of asbestos bodies in BAL from subjects with particular exposuresP De Vuyst, P Dumortier, P A Gevenois
Chest|June 1, 1987
BAL in asbestosisJ C Yernault, P De Vuyst, P Dumortier
La Revue Du Praticien|October 22, 1998
[Health effects of artificial mineral fibers]J C Pairon, P Brochard, P De Vuyst
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
The European Respiratory Journal|November 1, 1994
Chronic eosinophilic pneumonia (CEP) as a presenting feature of Churg-Strauss syndrome (CSS)S Steinfeld, M Golstein, P De Vuyst
The European Respiratory Journal|March 11, 1998
Asbestos, ergot drugs and the pleuraP De Vuyst, P Pfitzenmeyer, P Camus
American Journal of Respiratory and Critical Care Medicine|August 14, 2001
Pseudoasbestos bodies and fibers in bronchoalveolar lavage of refractory ceramic fiber usersP Dumortier, I Broucke, P De Vuyst
The European Respiratory Journal|July 10, 1998
Asbestos, ergot drugs and the pleuraP Camus, G Hillerdal, P De Vuyst
Revue Des Maladies Respiratoires|January 1, 1992
[Broncho-alveolar lavage. From technical aspects to standards of interpretation]B Wallaert, P De Vuyst, D Israel-Biet
The American Review of Respiratory Disease|December 1, 1986
Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosisJ C Yernault, P De Vuyst, P Dumortier
Respiratory Medicine|May 1, 1990
Concentration of tobramycin given by aerosol in the fluid obtained by bronchoalveolar lavageD Baran, P de Vuyst, H A Ooms
American Journal of Industrial Medicine|June 1, 1997
Analysis of asbestos bodies in BAL from subjects with particular exposuresP De Vuyst, P Dumortier, P A Gevenois
Chest|June 1, 1987
BAL in asbestosisJ C Yernault, P De Vuyst, P Dumortier
La Revue Du Praticien|October 22, 1998
[Health effects of artificial mineral fibers]J C Pairon, P Brochard, P De Vuyst
Pageof 10